Ligand Pharmaceuticals Incorporated

(LGND) Trade

By |

Profile

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Contact Information

Website: www.ligand.com
Email: investors@ligand.com
Main Phone: +1 858 550-7500
Address: 3911 Sorrento Valley Boulevard
Address 2: Suite 110
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92121

Issuer Information

Exchange: NSD
CEO: John L. Higgins
Employees: 39
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 133.39 $ 0.92 (0.69%)
Last Price 133.39 Change $ 0.92 Change % 0.69 Tick N/A
Bid 133.33 Bid Size 100.00 Ask 133.45 Ask Size 100.00
Open 134.78 High 134.78 Low 132.13 Prev Close 132.47
Last Trade Volume 167,978 52 Wk Hi 278.62 52 Wk Low 131.33
Market Cap 2.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,253,726.00 EPS (TTM) 7.31 PE Ratio 18.70 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 8 82
Number of Buys 4 30
Number of Sells 4 52
Net Activity -1445 -103238
Last 10 Buys Shares
Matthew W. Foehr 1,000
Charles S. Berkman 1,000
John W. Kozarich 1,000
Matthew W. Foehr 1,000
Jason M. Aryeh 1,000
Stephen L. Sabba 1,000
David M. Knott 1,000
John L. Higgins 1,000
Matthew W. Foehr 1,000
Melanie J. Herman 1,000
Last 10 Sell Shares
John L. Lamattina 1,000
John L. Higgins 1,000
Matthew W. Foehr 1,000
John W. Kozarich 1,000
Stephen L. Sabba 1,000
Jason M. Aryeh 1,000
Jason M. Aryeh 1,000
John L. Lamattina 1,000
Todd C. Davis 1,000
Todd C. Davis 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 182 182 182 182
Low Target Price Estimate 119 119 119 119
Mean Target Price Estimate 161 161 161 161
Standard Deviation 24.54 24.54 24.54 24.54
Date of Most Recent Estimate 06/04/18 05/11/18 05/11/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2 2 2 2